Suppliers and packagers for AMINO ACIDS

AMINO ACIDS

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
B Braun	AMINO ACIDS	amino acids	INJECTABLE;INJECTION	091112	ANDA	B. Braun Medical Inc.	0264-4500-00	8 CONTAINER in 1 CASE (0264-4500-00) / 1000 mL in 1 CONTAINER	2018-09-28
B Braun	AMINO ACIDS	amino acids	INJECTABLE;INJECTION	091112	ANDA	B. Braun Medical Inc.	0264-4500-05	4 CONTAINER in 1 CASE (0264-4500-05) / 2000 mL in 1 CONTAINER	2018-09-28

Last updated: July 29, 2025

ppliers for the Pharmaceutical Drug: Amino Acids

Introduction

Amino acids are fundamental organic compounds serving as the building blocks of proteins and critical components in pharmaceutical formulations. Their diverse applications range from dietary supplements and medical nutrition to drug development and specialty therapeutics. The demand for pharmaceutical-grade amino acids necessitates a robust supply chain comprising reputable manufacturers and suppliers capable of maintaining the purity, safety, and regulatory compliance essential for pharmaceutical applications. This report provides a comprehensive overview of key suppliers for pharmaceutical-grade amino acids, examining leading companies, their product portfolios, manufacturing capabilities, and market positioning.

Global Market Overview of Pharmaceutical Amino Acids

The global amino acids market is projected to reach approximately USD 9 billion by 2027, driven by increasing demand in nutraceuticals, pharmaceuticals, and personal care sectors (ResearchAndMarkets, 2022). The pharmaceutical-grade segment commands a significant share, emphasizing clean-label, high-purity, and biostable amino acids conforming to rigorous regulatory standards such as USP, EP, and FCC. The supply chain involves raw material sourcing, complex manufacturing processes, and strict quality controls to meet the pharmaceutical industry's demands.

Leading Suppliers of Pharmaceutical-Grade Amino Acids

1. Ajinomoto Co., Inc.

Overview
Ajinomoto is a global leader in amino acid manufacturing, with a long-standing reputation for producing high-quality, pharmaceutical-grade amino acids. Their extensive portfolio includes glutamine, lysine, threonine, and other essential amino acids used in injectable, oral, and medical nutrition formulations.

Manufacturing Capabilities
Ajinomoto operates multiple GMP-compliant manufacturing plants worldwide, ensuring consistent quality. Their proprietary fermentation technology enables high-purity amino acids suitable for pharmaceutical applications. The company's products comply with international pharmacopeia standards, including USP and EP.

Market Position
Ajinomoto’s global distribution network and R&D focus on bio-technology bolster its position as a preferred supplier in pharma-grade amino acids, especially for injectable formulations and clinical nutrition products.

2. Evonik Industries AG

Overview
Evonik specializes in specialty chemicals, including pharmaceutical amino acids like L-lysine, L-threonine, and L-tryptophan, produced via fermentation. Their amino acids are known for high purity and consistency, strictly adhering to pharmaceutical quality standards.

Manufacturing Capabilities
Their facilities utilize advanced fermentation technology coupled with robust purification processes, ensuring the removal of impurities. Evonik’s supply chain emphasizes sustainability and compliance with Good Manufacturing Practices (GMP).

Market Position
Evonik’s reputation for quality and innovation positions it as a key supplier of amino acids for parenteral nutrition and drug excipients. Their focus on customization and regulatory compliance enhances their market share in pharma applications.

3. CJ CheilJedang Corporation

Overview
South Korean conglomerate CJ CheilJedang has expanded its amino acid production into the pharmaceutical sector, producing high-purity amino acids aligning with medical standards. Their portfolio encompasses glutamine, lysine, and other amino acids used in injectable and oral formulations.

Manufacturing Capabilities
CJ employs state-of-the-art fermentation and purification techniques to ensure pharmaceutical-grade standards. Their manufacturing facilities are GMP-certified, meeting rigorous international requirements.

Market Position
CJ focuses on supply stability and compliance, actively targeting markets in Asia and expanding globally, especially in nutritional and pharmaceutical sectors.

4. Ajinomoto Natural Specialties, Inc.

Overview
A subsidiary of Ajinomoto, this unit emphasizes high-value amino acids, including pharmaceutical-grade L-glutamine and L-arginine. Their offerings target pharma, nutraceutical, and cosmetic industries.

Manufacturing Capabilities
They employ proprietary fermentation and purification protocols that guarantee pollutant-free, high-purity amino acids. Certification and compliance with ICH and WHO standards facilitate global distribution.

5. China National Biotec Group (CNBG)

Overview
CNBG is emerging as a significant supplier of pharmaceutical amino acids, primarily serving the Chinese and Asian markets. They produce a range of amino acids optimized for medical use, leveraging local raw material advantages.

Manufacturing Capabilities
The company’s manufacturing processes adhere to Chinese GMP standards and increasingly align with international regulations to expand export potential.

Other Notable Suppliers and Considerations

• Fujifilm Diosynth Biotechnologies offers custom fermentation solutions for amino acid production.
• Kyowa Hakko Kirin Co., Ltd. specializes in amino acids for parenteral nutrition and complex therapeutics.
• Coryn Biotech and smaller regional manufacturers focusing on niche applications and supply chain resilience.

Factors Influencing Supplier Selection

When choosing a supplier for pharmaceutical amino acids, key considerations include:

• GMP Compliance and Certifications: Ensure adherence to global regulatory standards, including USP, EP, FDA, and ICH guidelines.
• Product Purity and Specification Compliance: Confirm analytical specifications meet pharmaceutical requirements, typically including assays, impurities, and contaminants.
• Production Capacity and Supply Chain Stability: Assess supplier capacity to meet phased and large-volume demands.
• Regulatory Support and Documentation: Access to dossiers, Certificates of Analysis (CoA), and regulatory filings.
• Sustainability and Ethical Sourcing: Consider environmentally sustainable practices and traceability of raw materials.

Emerging Trends and Future Outlook

1. Biotechnological Innovations
Advances in fermentation technology and synthetic biology are enabling more efficient and cost-effective amino acid production, reducing reliance on traditional raw materials like petrochemical derivatives.

2. Regulatory Harmonization
Global harmonization of standards facilitates smoother import/export processes and broadens market access for suppliers compliant with international regulations.

3. Supply Chain Diversification
Recent disruptions have prompted companies to diversify supplier bases and establish regional manufacturing hubs, increasing supply resilience.

4. Focus on Sustainability
Eco-friendly production methods, waste reduction, and renewable raw materials gain importance, aligning with global corporate responsibility initiatives.

Key Takeaways

• Leading global manufacturers such as Ajinomoto, Evonik, and CJ CheilJedang dominate the supply of pharmaceutical-grade amino acids, maintaining rigorous quality and regulatory standards.
• Selection of suppliers should prioritize GMP certification, product purity, regulatory compliance, and supply chain stability.
• Technological and regulatory advancements are shaping the future landscape, emphasizing sustainable, biotech-driven production methods.
• Regional manufacturers and emerging players are increasingly filling gaps, especially in Asia, offering localized supply options.
• Comprehensive due diligence, including regulatory documentation and certification verification, is essential for procurement in pharma applications.

FAQs

1. What are the most commonly supplied amino acids for pharmaceutical use?
L-glutamine, L-lysine, L-threonine, L-tryptophan, and L-arginine are among the most prevalent due to their health benefits and functional roles in drug formulations.

2. How do pharmaceutical amino acids differ from nutraceutical-grade amino acids?
Pharmaceutical amino acids must meet stricter purity standards, with rigorous testing for contaminants, endotoxins, and residual solvents, and must comply with pharmacopeial standards such as USP and EP.

3. Are there regional differences in amino acid suppliers?
Yes; while global players dominate, Asia-based manufacturers like CJ and CNBG are prominent regional suppliers due to raw material advantages and domestic demand.

4. What role does sustainability play in sourcing pharmaceutical amino acids?
It is increasingly significant, with suppliers adopting environmentally friendly manufacturing processes, reducing waste, and ensuring traceability of raw materials to meet corporate responsibility and regulatory expectations.

5. How can companies ensure the quality and authenticity of amino acids from suppliers?
By verifying certifications, conducting audits, reviewing third-party testing and batch documentation, and ensuring supplier compliance with internationally recognized standards like GMP and pharmacopeial requirements.

Conclusion

The supply landscape for pharmaceutical-grade amino acids is characterized by prominent global players leveraging advanced biotechnology, stringent quality control, and regulatory compliance. As demand intensifies, especially in personalized medicine and specialized therapeutics, establishing strategic, compliant, and resilient supply partnerships remains paramount. Continuous innovations and emphasis on sustainability further underscore the evolving nature of this critical component of pharmaceutical manufacturing.

---

Sources:
[1] ResearchAndMarkets, "Amino Acids Market – Growth, Trends, and Forecast (2022-2027)"